Improving risk stratification for hospital mortality using troponin: is it time for a change of heart?

Affiliations

Comment

Alex F Manini. J Lab Precis Med. 2018 Jan.

. 2018 Jan:3:6.

doi: 10.21037/jlpm.2018.01.04. Epub 2018 Jan 23.

¹ Division of Medical Toxicology, Department of Emergency Medicine, the Icahn School of Medicine at Mount Sinai, Elmhurst Hospital Center, New York, NY, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Early troponin I in critical illness and its association with hospital mortality: a cohort study.
Docherty AB, Sim M, Oliveira J, Adlam M, Ostermann M, Walsh TS, Kinsella J, Lone NI. Docherty AB, et al. Crit Care. 2017 Aug 16;21(1):216. doi: 10.1186/s13054-017-1800-4. Crit Care. 2017. PMID: 28814347 Free PMC article.

1. Docherty AB, Sim M, Oliveira J, et al. Early troponin I in critical illness and its association with hospital mortality: a cohort study. Crit Care 2017;21:216. - PMC - PubMed
1. Manini AF, Stimmel B, Hoffman RS, et al. Utility of cardiac troponin to predict drug overdose mortality. Cardiovasc Toxicol 2016;16:355–60. - PMC - PubMed
1. Manini AF, Nelson LS, Stimmel B, et al. Incidence of adverse cardiovascular events in adults following drug overdose. Acad Emerg Med 2012;19:843–9. - PMC - PubMed
1. Kelley WE, Januzzi JL, Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 2009;55:2098–112. - PubMed
1. Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag 2011;7:597–603. - PMC - PubMed